Faeth Therapeutics, Inc. (FTH)
28.00
-1.05
(-3.61%)
USD |
NASDAQ |
Sep 25, 16:00
27.75
-0.25
(-0.89%)
After-Hours: 19:59
Faeth Therapeutics Price to Book Value : 4.182 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 4.182 |
| September 24, 2026 | 4.339 |
| September 23, 2026 | 4.712 |
| September 22, 2026 | 4.989 |
| September 21, 2026 | 4.972 |
| September 18, 2026 | 5.153 |
| September 17, 2026 | 5.247 |
| September 16, 2026 | 5.114 |
| September 15, 2026 | 5.283 |
| September 14, 2026 | 5.838 |
| September 11, 2026 | 5.592 |
| September 10, 2026 | 5.825 |
| September 09, 2026 | 5.395 |
| September 08, 2026 | 5.855 |
| September 04, 2026 | 5.982 |
| September 03, 2026 | 5.825 |
| September 02, 2026 | 5.843 |
| September 01, 2026 | 5.154 |
| August 31, 2026 | 4.894 |
| August 28, 2026 | 5.054 |
| August 27, 2026 | 5.039 |
| August 26, 2026 | 4.924 |
| August 25, 2026 | 5.156 |
| August 24, 2026 | 5.184 |
| August 21, 2026 | 4.780 |
| Date | Value |
|---|---|
| August 20, 2026 | 4.794 |
| August 19, 2026 | 4.945 |
| August 18, 2026 | 4.929 |
| August 17, 2026 | 4.894 |
| August 14, 2026 | 4.830 |
| August 13, 2026 | 4.264 |
| August 12, 2026 | 4.388 |
| August 11, 2026 | 4.481 |
| August 10, 2026 | 4.267 |
| August 07, 2026 | 3.643 |
| August 06, 2026 | 3.656 |
| August 05, 2026 | 3.673 |
| August 04, 2026 | 3.809 |
| August 03, 2026 | 4.084 |
| July 31, 2026 | 4.069 |
| July 30, 2026 | 4.305 |
| July 29, 2026 | 4.321 |
| July 28, 2026 | 4.351 |
| July 27, 2026 | 4.367 |
| July 24, 2026 | 4.225 |
| July 23, 2026 | 4.146 |
| July 22, 2026 | 4.281 |
| July 21, 2026 | 4.237 |
| July 20, 2026 | 4.210 |
| July 17, 2026 | 3.864 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Opus Genetics, Inc. | -- |
| Perspective Therapeutics, Inc. | 0.8877 |
| Praxis Precision Medicines, Inc. | 5.845 |
| Nuvectis Pharma, Inc. | 59.43 |
| Jade Biosciences, Inc. | 2.083 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0002 |
| Price | 28.00 |
| Earnings Yield | -505.9% |
| Market Cap | 723.32M |
| PEGY Ratio | -0.0002 |